Equity · Healthcare
WVE
Wave Life Sciences Ltd. · NasdaqGM
The line runs $6.41 on 21 May through $5.82 on 17 July, on a scale from $5.5 to $7.0. Days the market did not trade hold the previous close, flat.
The chart above plots the price of WVE over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 39 sessions over that window: $6.41 on 21 May 2026 through $5.82 on 17 July 2026.
Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 19, 2026
WVE insider trades
WVE has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 30 March 2026.
Showing the 12 most recent of 21 open-market trades in this window. The figures above count all of them.
Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.
Showing the 12 most recent of 18 compensation filings in this window. The figures above count all of them.
WVE reported financials
WVE reported revenue of $42.7M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$204.4M.
Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
WVE earnings
no date announced in SEC filings yet
Reported figures & scheduled dates · SEC EDGAR filings
WVE institutional holders
12 of the 45 institutional funds we track reported a WVE position for the quarter ended 30 Jun 2026 — a combined $147.5M; the latest of those filings landed 14 Aug 2026.
Showing the 10 largest of 12 reported positions. The figures above count all of them.
Source: SEC EDGAR 13F filings
WVE fails-to-deliver
On 31 Jul 2026, 62 shares of WVE failed to deliver (about $357).
Source: SEC fails-to-deliver (CNS) data